Bo M. Ku
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Key barriers in utilizing advanced T-cell engager strategies on solid tumors.
Journal: Expert review of anticancer therapy
Published: September 07, 2026
Precision Immunotherapy: Revolutionizing Cancer Treatment With Targeted Innovations.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 07, 2026
Leptomeningeal Metastasis in Non-Small-Cell Lung Cancer with Actionable Genomic Alterations: Pathogenesis, Diagnosis, and Emerging Therapeutic Strategies.
Journal: Cancers
Published: April 30, 2026
Discovery of TCR-like antibodies to the KRAS G12D neoantigen via in silico-in vitro workflow.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 08, 2025
Updates on the treatment of epidermal growth factor receptor-mutant non-small cell lung cancer.
Journal: Cancer
Published: June 10, 2024
Longitudinal Monitoring of Circulating Tumor DNA From Plasma in Patients With Curative Resected Stages I to IIIA EGFR-Mutant Non-Small Cell Lung Cancer.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: March 27, 2023
A Phase 2 Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumors (KCSG LU17-21).
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 31, 2022
Association of T Cell Senescence with Radiation Pneumonitis in Patients with Non-small Cell Lung Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: March 08, 2022
Dynamics of Circulating Immune Cells During Chemoradiotherapy in Patients with Non-Small Cell Lung Cancer Support Earlier Administration of Anti-PD-1/PD-L1 Therapy.
Journal: International journal of radiation oncology, biology, physics
Published: October 28, 2021
Longitudinal monitoring by next-generation sequencing of plasma cell-free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitors.
Journal: Cancer medicine
Published: October 04, 2021
Last Updated: 09/26/2026